In March 2019 the American Botanical Council published a proprietary botanical ingredient monograph summarizing the scientific and clinical studies of BCM-95^® (also known as Curcugreen^TM), patented extract preparation of turmeric (Curcuma longa) rhizome combined with essential oil of turmeric, standardized to levels of curcuminoids.

Thirteen clinical studies conducted on BCM-95 are reviewed in the monograph. These trials deal with its potential benefits for the following conditions areas:  mental health, joint health, immune health, pain, and cancer chemoprevention. 

In January 2010 the American Botanical Council published a proprietary botanical ingredient monograph summarizing the scientific and clinical studies of Pycnogenol^®, a patented dietary ingredient from French maritime pine bark (Pinus pinaster). In February 2019, ABC published a revised and updated version of the Pycongenol monograph.

Studies of Pycnogenol reviewed in the monograph include clinical trials evaluating cardiovascular benefits, improvement in blood sugar control, ability to reduce difficulties associated with chronic venous insufficiency and problems related to thrombosis, decrease of edema, benefit to children with attention deficit hyperactivity disorder (ADHD), adjunct therapy for patients with asthma, reduction of menstrual pain, and improvement of subjective symptoms of osteoarthritis in the knee.

is an extensively researched, peer-reviewed literature review covering the pharmacological research and 6 preliminary human clinical trials on this patented pomegranate juice, demonstrating this juice’s safety and strong antioxidant activity, as well as its potential benefits to possibly reduce cardiovascular risk factors.

is an extensively researched, peer-reviewed literature review covering the pharmacological and human clinical research on COLD-fX, aka CVT-E002, a proprietary, patented fraction of saccharides from the roots of American ginseng (Panax quinquefolius), which the Canadian government has approved for use to prevent and/or treat symptoms related to colds and flu, complete with safety data, recommended dosage levels, etc.

In February 2009 the American Botanical Council published a product-specific monograph summarizing the scientific and clinical studies of Sinupret^®, a clinically-tested combination of extracts of five traditional European herbs. Sinupret is widely used in Germany and other countries for upper respiratory tract health, including conditions associated with sinusitis and bronchitis.

Studies of Sinupret reviewed in the monograph include four clinical trials regarding acute sinusitis, two clinical trials regarding chronic sinusitis, one meta-analysis of clinical trials evaluating treatment of sinusitis, two clinical trials regarding bronchitis, and a post-marketing surveillance study of patients with bronchitis.